news | Market Exclusive

Home Tags News

Biotech Gainers On Tuesday: Amicus Therapeutics, Inc. (NASDAQ:FOLD) and Ionis Pharmaceuticals...

- November 8, 2016 0

Horizon Pharma PLC (NASDAQ:HZNP) Could Double Its Annual Sales Potential On...

- November 8, 2016 0

AveXis Inc (NASDAQ:AVXS): Of Course The FDA Didn’t Ask For Placebo...

- November 3, 2016 1

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Isn’t Out Of The Woods With Firdapse...

- November 1, 2016 0

Here Are Three Big Biotech Movers And Our Take On What’s...

- October 28, 2016 0

Here’s Our Take On The Latest ProQR Therapeutics NV (NASDAQ:PRQR) Release

- October 27, 2016 0

What To Watch From The Upcoming Cerecor Inc (NASDAQ:CERC) Release

- October 24, 2016 0

Here’s What You Need To Know About ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

- October 17, 2016 0

Here’s What We Want To See From Adaptimmune Therapeutics PLC –...

- October 13, 2016 0

Here’s Our Take On Neurocrine Biosciences, Inc. (NASDAQ:NBIX)’s Ingrezza

- October 12, 2016 0

1...181920 Page 19 of 20

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: news